Journal of Human Immunity

Journal of Human Immunity

jhumimmunity.org

Journal of Human Immunity (JHI) is the official open access journal of the International Alliance for Primary Immunodeficiency Societies (IAPIDS). Published by @rupress.org 🌐 jhumimmunity.org

👤 Joined on 14 January 2025

460

Followers

150

Following

497

Total Posts

📜 Kullanıcı Geçmişi

  • 14 Oca 2025, 15:06
    🎉 Bluesky'e katıldı - İlk kullanıcı adı: @jhumimmunity.bsky.social
  • 14 Oca 2025, 23:28
    ✏️ Kullanıcı adı değişti: @jhumimmunity.bsky.social → @jhumimmunity.org

🚫 Blokladığı Kullanıcılar

❤️ Beğendiği Gönderiler

Turvey Lab
14 October 2026 13:08

Our new IRF4 paper follows all 10 known patients with the p.T95R variant: profound combined immunodeficiency, severe infections, and progressive lung disease. HSCT can be curative, but timing matters. Thanks to our international team and the families.

Show Post

A pleasure to work with Ofer Zimmerman & @washumedicine.bsky.social heme to make the diagnosis in this adult woman who had symptoms for two decades. TLR8 GOF is X linked DOMINANT -males & females. Our original cohorts were younger (I’m a pediatrician!) there are more older adults out there

Show Post
Manish Butte
01 September 2026 13:28

We all know recurrent infections is a hallmark of many primary immunodeficiencies, but what really is "recurrent"? In the electronic health record, recurrence is far from obvious. Aaron figured out a way to tease recurrence from the data. The impact is finding immune deficiency patients sooner. #IEI

Show Post

Thank you, Anne, Jean-Laurent, and Vivien, for this wonderful News & Views, and congratulations to Trine Mogensen and colleagues on their complementary study. It's exciting to see independent discoveries establish OSMRβ deficiency as a new inborn error of immunity. @casanovalab.bsky.social

Show Post

A patient's search for answers led to the discovery of a new type of immune disorder Researchers identified a mosaic mutation affecting only a specific subgroup of immune cells, opening new possibilities for precision diagnosis and targeted treatment for patients with unexplained immune disorders.

Show Post

Select language

Install App

Install App